Werewolf Therapeutics, Inc. - HOWL
About Gravity Analytica
Recent News
- 06.12.2025 - Werewolf Therapeutics to Participate in the BIO International Convention
- 06.12.2025 - Werewolf Therapeutics to Participate in the BIO International Convention
- 06.12.2025 - Werewolf Therapeutics to Participate in the BIO International Convention
- 06.05.2025 - Jefferies Global Healthcare Conference
- 06.05.2025 - Jefferies Global Healthcare Conference
- 05.29.2025 - Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference
- 05.29.2025 - Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference
- 05.20.2025 - HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124
- 05.20.2025 - HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124
- 05.14.2025 - Bank of America Securities 2025 Health Care Conference